RBM10 Deficiency Is Associated With Increased Immune Activity in Lung Adenocarcinoma

Abstract

Our study demonstrates that RBM10 deficient LUADs show higher HLA expression and immune cell infiltration, and some immune checkpoint molecules are also highly expressed. In brief, RBM10 deficiency could enhance anti-tumor immunity in LUAD.